Cargando…

Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer

BACKGROUND: Ovarian cancer is the most lethal gynecologic malignancy, but its etiology remains poorly understood. This study investigated the role of Fli-1 in ovarian carcinogenesis and disease survival. METHODS: Fli-1 protein expression was evaluated by immunohistochemistry in 104 primary epithelia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Wei, Hu, Lingyun, Li, Wei, Wang, Guanjun, Li, Yan, Yan, Lei, Li, Ailing, Cui, Jiuwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089852/ https://www.ncbi.nlm.nih.gov/pubmed/24923303 http://dx.doi.org/10.1186/1471-2407-14-424

Ejemplares similares

Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia
por: SONG, WEI, et al.
Publicado: (2013)

The oncogenic and prognostic role of PDK1 in the progression and metastasis of ovarian cancer
por: Yao, Shasha, et al.
Publicado: (2021)

Cancer Stem Cell Marker Musashi-1 rs2522137 Genotype Is Associated with an Increased Risk of Lung Cancer
por: Wang, Xu, et al.
Publicado: (2014)

Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer
por: Li, Jun, et al.
Publicado: (2016)

EphA8 is a prognostic marker for epithelial ovarian cancer
por: Liu, Xiaoqin, et al.
Publicado: (2016)

PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer
por: Song, Zongchang, et al.
Publicado: (2015)

Rac GTPase activating protein 1 promotes oncogenic progression of epithelial ovarian cancer
por: Wang, Chuanjiang, et al.
Publicado: (2017)

Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer
por: Zhang, Lingyun, et al.
Publicado: (2022)

Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma
por: Chang, Bin, et al.
Publicado: (2018)

Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway
por: Li, Lingyu, et al.
Publicado: (2017)

Sialyl Tn as a prognostic marker in epithelial ovarian cancer.
por: Kobayashi, H., et al.
Publicado: (1992)

The LIM Protein AJUBA is a Potential Oncogenic Target and Prognostic Marker in Human Cancer via Pan-Cancer Analysis
por: Song, Na, et al.
Publicado: (2022)

LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis
por: Liu, Yulan, et al.
Publicado: (2018)

Serum lncRNA LOXL1‐AS1 is a diagnostic and prognostic marker for epithelial ovarian cancer
por: Liu, Chun‐Na, et al.
Publicado: (2020)

Prognostic Significance of Lymphovascular Space Invasion in Epithelial Ovarian Cancer
por: Chen, Ming, et al.
Publicado: (2015)

COPS5 Conferred the Platinum Resistance in Epithelial Ovarian Cancer
por: Zhang, Hongqin, et al.
Publicado: (2022)

Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer
por: Guan, Luyao, et al.
Publicado: (2020)

Effect of the 3q26-coding oncogene SEC62 as a potential prognostic marker in patients with ovarian neoplasia
por: Radosa, Julia C., et al.
Publicado: (2023)

A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1
por: Chen, Naifei, et al.
Publicado: (2018)

Inhibition of HIV-1 Viral Infection by an Engineered CRISPR Csy4 RNA Endoribonuclease
por: Guo, Rui, et al.
Publicado: (2015)

Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer
por: Wei, Wei, et al.
Publicado: (2016)

Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer
por: Song, Wei, et al.
Publicado: (2015)

Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis
por: Hao, Wende, et al.
Publicado: (2021)

PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer
por: Chai, Hong-Juan, et al.
Publicado: (2017)

The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
por: Zheng, Kaiwen, et al.
Publicado: (2021)

WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells
por: Yu, Hai-Lan, et al.
Publicado: (2019)

A Novel Mechanism by Which SDF-1β Protects Cardiac Cells From Palmitate-Induced Endoplasmic Reticulum Stress and Apoptosis via CXCR7 and AMPK/p38 MAPK-Mediated Interleukin-6 Generation
por: Zhao, Yuguang, et al.
Publicado: (2013)

Downregulation of the ubiquitin ligase KBTBD8 prevented epithelial ovarian cancer progression
por: Du, Lei, et al.
Publicado: (2020)

Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer
por: Siraj, Abdul K., et al.
Publicado: (2020)

Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer
por: Jung, MoonSun, et al.
Publicado: (2018)

Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer
por: Watanabe, Takafumi, et al.
Publicado: (2021)

Prognostic Significance of CA125 Dynamic Change for Progression Free Survival in Patients with Epithelial Ovarian Carcinoma
por: Li, Zemin, et al.
Publicado: (2020)

Knockdown of COPS3 Inhibits Lung Cancer Tumor Growth in Nude Mice by Blocking Cell Cycle Progression
por: Pang, Jianan, et al.
Publicado: (2017)

Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments
por: Chang, Xiaoying, et al.
Publicado: (2021)

Circulating Mitochondrial DNA is Linked to Progression and Prognosis of Epithelial Ovarian Cancer
por: Meng, Xiaodan, et al.
Publicado: (2019)

Identifying Potential Markers for Monitoring Progression to Ovarian Cancer Using Plasma Label-free Proteomics
por: Wang, Wenjie, et al.
Publicado: (2021)

The clinical validity of miR-126 as a prognostic marker in epithelial ovarian cancer
por: Liu, Lin, et al.
Publicado: (2023)

Antitumor potential of a synthetic interferon-alpha/PLGF-2 positive charge peptide hybrid molecule in pancreatic cancer cells
por: Yin, Hongmei, et al.
Publicado: (2015)

Chemotherapy-Induced Neutropenia as a Prognostic Factor in Patients With Advanced Epithelial Ovarian Carcinoma
por: Xu, Yaping, et al.
Publicado: (2023)

Utility of Preoperative Inflammatory Markers to Distinguish Epithelial Ovarian Cancer from Benign Ovarian Masses
por: Li, Lian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sbbactjrktmpenvrameqqcdumf